Stay updated with breaking news from India Tb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune.
Accurate tools for detecting TB, medication for curing it, must be made widely available.
The 18-month study was undertaken by researchers from B J Government Medical College (BJGMC) and Johns Hopkins University (JHU) to assess the WHO-recommended 3HP regime among People Living with HIV/AIDS (PLHIV), children living with HIV and child contacts of pulmonary TB patients.
Increasing TB incidence and deaths, large gaps in reporting, more drug resistance and reduced funding all contribute to India's downslide in TB eradication efforts, contributing heavily to the worsening global scenario as well.